Financialsexperimental
KELLANOVA. Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in millions · shares in millions · per-share amounts in USD
| Income Statement | Q3 FY25 27 Sept 2025 | Q2 FY25 28 Jun 2025 | Q1 FY25 29 Mar 2025 | Q4 FY24 28 Dec 2024 | Q3 FY24 28 Sept 2024 | Q2 FY24 29 Jun 2024 | Q1 FY24 30 Mar 2024 | Q4 FY23 30 Dec 2023 | Q3 FY23 30 Sept 2023 | Q2 FY23 01 Jul 2023 | Q1 FY23 01 Apr 2023 | Q4 FY22 31 Dec 2022 | Q3 FY22 01 Oct 2022 | Q2 FY22 02 Jul 2022 | Q1 FY22 02 Apr 2022 | Q4 FY21 01 Jan 2022 | Q3 FY21 02 Oct 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 3,260 | 3,203 | 3,083 | 3,124* | 3,233 | 3,192 | 3,200 | 1,089* | 3,939 | 4,041 | 4,053 | 3,833* | 3,946 | 3,864 | 3,672 | 3,420* | 3,622 |
| Cost of goods sold | 2,176 | 2,113 | 2,024 | 1,947* | 2,057 | 2,031 | 2,169 | 692* | 2,596 | 2,708 | 2,843 | 2,673* | 2,793 | 2,721 | 2,513 | 2,415* | 2,457 |
| Selling, general and administrative expense | 632 | 652 | 629 | 646* | 720 | 668 | 638 | 323* | 861 | 824 | 770 | 825* | 785 | 728 | 642 | 676* | 718 |
| Operating profit | 452 | 438 | 430 | 531* | 456 | 493 | 393 | 74* | 482 | 509 | 440 | 335* | 368 | 415 | 517 | 329* | 447 |
| Interest expense | 60 | 63 | 63 | 70* | 75 | 83 | 83 | 58* | 83 | 82 | 80 | 69* | 39 | 54 | 56 | 51* | 55 |
| Other income (expense), net | 8 | 9 | 11 | -5* | 21 | 33 | 43 | -200* | -24 | 36 | 26 | -408* | 54 | 60 | 74 | 282* | 0 |
| Income before income taxes | 400 | 384 | 378 | 456* | 402 | 443 | 353 | -184* | 375 | 463 | 386 | -142* | 383 | 421 | 535 | 560* | 392 |
| Income taxes | 89 | 83 | 73 | 91* | 34 | 97 | 82 | -36* | 104 | 104 | 86 | -39* | 74 | 97 | 112 | 129* | 92 |
| Earnings (loss) from unconsolidated entities | 3 | 2 | 3 | 3* | 2 | 1 | 0 | 2* | -1 | 3 | 2 | 3* | 3 | 2 | 1 | 3* | 5 |
| Net income | 270 | 362 | 302 | -100* | 312 | 326 | 424 | 434* | 305 | ||||||||
| Net income (loss) | 314 | 303 | 308 | 368* | 370 | 347 | 271 | ||||||||||
| Net income (loss) attributable to noncontrolling interests | 5 | 4 | 4 | 3* | 3 | 3 | 4 | 3* | 1 | 5 | 4 | -2* | 2 | 0 | 2 | 1* | -2 |
| Net income attributable to Kellanova | 309 | 299 | 304 | 365* | 367 | 344 | 267 | 27* | 269 | 357 | 298 | -98* | 310 | 326 | 422 | 433* | 307 |
| Income from discontinued operations, net of taxes | 0* | 0 | 0 | 0 | |||||||||||||
| Net earnings (loss) per common share - basic | 0.89 | 0.86 | 0.88 | 1.07 | 1.01 | 0.78 | 0.79 | 1.04 | 0.87 | 0.91 | 0.96 | 1.24 | 0.9 | ||||
| Earnings from continuing operations, per basic share | 1.07 | 1.01 | 0.78 | ||||||||||||||
| Earnings from discontinued operations, per basic share | 0 | 0 | 0 | ||||||||||||||
| Net earnings (loss) per common share - diluted | 0.88 | 0.85 | 0.87 | 1.05 | 1 | 0.78 | 0.78 | 1.03 | 0.86 | 0.9 | 0.95 | 1.23 | 0.89 | ||||
| Earnings from continuing operations, per diluted share | 1.05 | 1 | 0.78 | ||||||||||||||
| Basic (in shares) | 348 | 347 | 346 | 343 | 342 | 341 | 342 | 343 | 342 | 341 | 339 | 340 | 341 | ||||
| Earnings from discontinued operations, per diluted share | 0 | 0 | 0 | ||||||||||||||
| Diluted (in shares) | 350 | 350 | 349 | 347 | 345 | 344 | 345 | 345 | 345 | 344 | 342 | 342 | 343 | ||||
| Actual shares outstanding at period end (in shares) | 348 | 348 | 347 | 345 | 342 | 342 | 343 | 342 | 343 | 341 | 340 | 338 | 341 |